Ryan Cohlhepp, President and COO at Bicara Therapeutics Inc. (BCAX), sold 149 shares at $18.02 ($3K) on 2026-01-15, disclosed to the SEC on 2026-01-20.
Scheduled sale ($3k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCAX | SELL | 2026-07-10 | $833K | — | Filing → |
| BCAX | SELL | 2026-05-18 | $254K | — | Filing → |
| BCAX | SELL | 2026-04-17 | $288K | — | Filing → |